Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Annals of the New York Academy of Sciences|November 25, 2010
The genetics of type 2 diabetes: what have we learned from GWAS?Liana K Billings, Jose C Florez
Diabetic Medicine : a Journal of the British Diabetic Association|June 16, 2022
Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetesRoopa Mehta, Liana K Billings, Andreas Liebl, et al.
Annals of Medicine|June 29, 2021
Leveraging advances in diabetes technologies in primary care: a narrative reviewBruce Bode, Aaron King, David Russell-Jones, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Health-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes MellitusLiana K Billings, Yehuda Handelsman, Michael Heile, et al.
Diabetes, Obesity & Metabolism|April 20, 2026
Hyperaldosteronism in the Pathophysiology and Management of Cardiovascular-Kidney-Metabolic SyndromeEvan Zeitler, Klara R Klein, Ildiko Lingvay, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|April 24, 2023
Effect of a Type 2 Diabetes-Focused Visit Improvement Initiative on Therapeutic Inertia and Glycemic Control in Primary CareLauren Oshman, Matthew Biszewski, Francesca Carlock, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2018
Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic ImplicationsMichael Heile, Kathleen Wyne, Liana K Billings, et al.
Journal of Diabetes Science and Technology|March 28, 2025
Envisioning Tools to Help Classify Type 1 Diabetes and Type 2 Diabetes in New-Onset Adult DiabetesAlessandra T Ayers, Cindy N Ho, Liana K Billings, et al.
Advances in Therapy|October 25, 2022
Living with Chronic Kidney Disease and Type 2 Diabetes Mellitus: The Patient and Clinician PerspectiveSusanne B Nicholas, Eugene E Wright, Liana K Billings, et al.
Pageof 6